2 recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 2 |
Follow Aggressive Lymphoma: new trials by email Literature Review of Aggressive Lymphoma trials Research Report on Aggressive Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma Early Palliative Care - Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Not applicable | Recruiting | University Health Network, Toronto | 144 | 2024-07-18 | 2025-12-03 |
| Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma Al18F-NOTA-FAPI, Al18F-NOTA-grazytracer/68Ga-grazytracer - Aggressive Lymphoma | Not applicable | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 94 | 2024-07-11 | 2026-10-07 |
Lymphoma, B-Cell (1) · Multiple Myeloma (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · University Health Network, Toronto (1)
Canada (1) · China (1)
Breffni Hannon, MB BCh BAO, MMedSci, MCFP (1) · Xuejuan Wang, M.D. (1)